Back

From guidelines to precision care: a personalised approach to heart failure management using heterogeneous treatment effects

30 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Innovative diagnostics and treatments in heart failure Heart Failure with Reduced Ejection Fraction (HFrEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mrs Hajar Ghaem Sigarchian

Thomas More University - Geel Campus, Geel (Belgium)

6 More presentations in this session

Presentation thumbnail
Prognostic impact of heart failure phenotype based on left ventricular ejection fraction and HFA-PEFF score after surgical or transcatheter aortic valve replacement
Doctor T. Ohmori (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Circulating ketone bodies are inversely associated with myocardial ketone body oxidative capacity in human failing hearts
Mr J. Schmidt (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Ketone treatment has favourable effects on cardiac energy metabolism in patients with chronic heart failure
Doctor N. Abild Jespersen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Atrial cardiomyocytes lose contractile reserve with increased frequency and adrenergic stimulation in a murine HFpEF model
Mr H. Zhang (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Prevalence of heart failure with preserved ejection fraction (HFpEF) and symptoms in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
Doctor M. Pareek (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Innovative diagnostics and treatments in heart failure

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Session
Personalized approach in real-world heart failure management: are we ready for the revolution?
28 August 2022
thumbnail
Congress Presentation
Machine learning–based identification of mortality risk factors in hospitalized heart failure patients: a multicenter real-world study
28 August 2026
thumbnail
Congress Presentation
Cardiovascular outcomes and mortality associated with proton pump inhibitors versus histamine-2 receptor antagonists in patients with heart failure: a target trial emulation study
28 August 2026
thumbnail
Congress Presentation
Real-world evaluation of an algorithmic machine-learning-guided testing approach in stable chest pain: a multinational, multicohort study
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources